跳轉至內容
Merck
全部照片(1)

文件

G004661

HPLC Analysis of Sibutramine Enantiomers on Astec® CHIROBIOTIC® V2

application for HPLC

登入查看組織和合約定價


About This Item

技術

HPLC: suitable

測試參數

column: CHIROBIOTIC V2, 25 cm x 4.6 mm I.D., 5 μm particles (15024AST)
mobile phase: 15 mM ammonium formate in methanol
flow rate: 1 mL/min
column temp.: 25 °C
detector: UV, 230 nm
injection: 10 μL
sample: 1 mg/mL in methanol

適合性

application for HPLC

應用

pharmaceutical (small molecule)

分析報告

Sibutramine, one of a few drugs approved for long-term treatment of obesity, is a chiral compound. The (R) enantiomer has the desired effect of reducing body weight and food intake, but the (S) enantiomer has the opposite effect: A perfect example of why chiral HPLC is important to pharmaceutical and clinical analysts. Astec® CHIROBIOTIC® V2 successfully separates sibutramine enantiomers, using a simple, MS-friendly mobile phase.

法律資訊

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC

分析物

描述

    Sibutramine hydrochloride monohydrate, ≥98% (HPLC), solid

Choose from one of the most recent versions:

分析證明 (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務